Interpreting results from thrombolytic megatrials: distinguishing fact from fiction.
Brophy
J M
JM
Department of Medicine, Centre Hospitalier de Verdun, Québec. 72260_2210@compuserve.com
D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013300:Streptokinase / Q000191:economics / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000191:economics / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator